The Evolution of Compliance in the Life Sciences Industry – A Discussion with the Chief Compliance Officers of Alexion and Otsuka

Life Sciences companies operate in one of the world’s most complex and continually evolving regulatory environments. To succeed in this industry, organizations rely on their compliance leaders to partner with them to protect and drive their business strategy — effectively identify, monitor, and mitigate risks — as they seek to push the boundaries of innovation, and develop and launch new products.

Join our partners Joy Dowdle and Jane Yoon for a discussion with industry veterans Indrani Franchini, Chief Compliance Officer of Alexion Pharmaceuticals Inc., and Jennifer McGee, Chief Compliance Officer of Otsuka America Pharmaceutical Inc. for an engaging discussion on the evolution of compliance in the industry, and thoughts on strategies for future success.

Please join us for this webinar within our Diverse Voices in Life Sciences series, providing a unique experience to gain access to our panelists' insights and explore areas of most interest to you. If you missed this event, please access the recording here.

All webinars

• Navigating Compliance Risks in Clinical Trials (September 2022)
• Current Issues, Best Practices, and Strategies for Compliance in R&D and Medical Affairs (May 2022)
• Life Sciences Innovation: New Opportunities, New Challenges (November 2021)
• Joining Forces to Advance LGBTQ+ Health and Well-Being (July 2021)
• The Evolution of Compliance in the Life Sciences Industry – A Discussion with the Chief Compliance Officers of Alexion and Otsuka (June 2021)
• The First 100 Days as CLO: How to Ensure Success (May 2021)